Mitigating the effects of COVID-19 on the work of a children's clinical research facility

Allyson Gray1

  • 1National Institute for Health Research Clinical Research Facility, Great Ormond Street Hospital for Children NHS Foundation Trust, London, England.

Insights

The COVID-19 pandemic disrupted pediatric clinical research, necessitating adaptations in study delivery and staff work. Some pandemic-induced changes positively impacted research operations, offering broader applications for clinical settings.

Area of Science:

  • Pediatric Clinical Research
  • Healthcare Management
  • Infectious Disease Epidemiology

Background:

  • The COVID-19 pandemic significantly impacted global healthcare systems and research operations.
  • Clinical trials faced unprecedented challenges, including pausing ongoing studies and delaying new ones.
  • Patient safety and outcomes remained paramount during trial adjustments.

Purpose of the Study:

  • To reflect on the effects of the COVID-19 pandemic on a UK-based children's clinical research facility.
  • To describe the mitigation strategies implemented to address pandemic-related disruptions.
  • To identify positive changes and lessons learned applicable to wider research and clinical settings.

Main Methods:

  • Qualitative reflection on operational changes during the pandemic.
  • Description of adaptations in study intervention delivery.
  • Analysis of changes in staff working practices and their impact.

Main Results:

  • The pandemic necessitated significant adjustments to ongoing and planned clinical trials.
  • Innovations in study delivery and staff working methods were implemented.
  • Several adaptations yielded positive outcomes with potential for long-term benefits.

Conclusions:

  • The COVID-19 pandemic profoundly affected pediatric clinical research, requiring rapid adaptation.
  • Mitigation strategies and operational changes led to positive, lasting improvements.
  • Lessons learned from this single facility offer valuable insights for broader research and clinical practice.

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.6K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.5K
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
172
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
190
Controls in Experiments01:13

Controls in Experiments

When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
13.3K